UF Health PROTAC cancer treatment received FDA approval for clinical trials March 23, 2021 A drug that could treat leukemia, lymphoma and lung and breast cancers has been given approval by the Food and Drug Administration (FDA) to proceed to clinical trial. It is the first drug of its kind to receive this approval from the FDA.Read the full article here.Source: Mansur Shaheen - State of Reform Prostate Cancer News
A drug that could treat leukemia, lymphoma and lung and breast cancers has been given approval by the Food and Drug Administration (FDA) to proceed to clinical trial. It is the first drug of its kind to receive this approval from the FDA.Read the full article here.Source: Mansur Shaheen - State of Reform
